Core Viewpoint - Hohhot Economic and Technological Development Zone is accelerating the layout of the biopharmaceutical industry, aiming to create a high-quality development environment and attract more biopharmaceutical enterprises to settle in the region [1][4] Group 1: Project Developments - The transdermal patch production project by Hegao Pharmaceutical Co., Ltd. and the intelligent manufacturing factory project by Xiling Biological Technology Co., Ltd. have simultaneously commenced construction [1] - The total investment for the two projects in the Yangtze River Delta and Inner Mongolia is 270 million yuan, focusing on transdermal drug delivery technology innovation and recombinant humanized active ingredient research [2] Group 2: Policy and Support - Hohhot City has introduced several policies to support high-quality development in the biopharmaceutical sector, including measures to build a strong technological city and support synthetic biology [1][4] - The development zone provides "one-stop" services in areas such as site selection, funding, project application, and technological support to facilitate project implementation [1][2] Group 3: Industry Ecosystem - The biopharmaceutical industry in Hohhot has formed a robust ecosystem, with 22 biopharmaceutical companies currently operating in the development zone, accounting for one-third of the city's total [3] - Key players in the industry include Jin Yu Biotechnology Co., Ltd. for biological vaccines, Fufeng Group Co., Ltd. and Qilu Pharmaceutical Group Co., Ltd. for biological fermentation, and Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. for biopharmaceuticals [3] Group 4: Future Outlook - The industrial output value of the biopharmaceutical sector in Hohhot is projected to reach 11.09 billion yuan in 2024, with a year-on-year growth of 2% [4] - The development zone plans to enhance its industrial ecosystem, attract more high-quality biopharmaceutical enterprises, and strengthen policy support and service guarantees to promote innovation and integration of industry, academia, and research [4]

Group 1 - The 34th Harbin International Economic and Trade Fair showcased Jixi City with a theme of "Graphite Capital, Poetic Jianghu," featuring a 150 square meter exhibition hall that highlights local industries and cultural characteristics [2] - A record number of over 80 enterprises from Jixi participated, covering various sectors such as industrial manufacturing, technological innovation, bio-economy, digital economy, mineral economy, green food, and cultural tourism, with nearly 300 exhibits on display [2] - The exhibition focused on "special, refined, unique, and new" products, presenting achievements through physical displays and models, while also promoting cooperation with Russian cities and enterprises [2][3] Group 2 - Jixi organized seven major supporting activities during the fair, the highest number in its history, including a conference on building "China's Acanthopanax Capital" and promoting high-quality development in the biopharmaceutical industry [3] - Governmental discussions were held with cities from Russia and Kyrgyzstan to deepen international cooperation, alongside a series of promotional and live-streaming events [3] - The exhibition integrated cultural performances and local specialty product displays, achieving a deep fusion of exhibition, discussion, and negotiation [3]

Core Insights - The establishment of the Nanjing Biomedical Sub-center has facilitated the transfer and commercialization of research outcomes from 68 universities, resulting in 1,123 selected pharmaceutical achievements and 31 projects being established [1][2] - The sub-center has created a financial support system with a scale of 8.4 billion yuan, including various funding sources to assist startups and projects [2] Group 1 - The Nanjing Biomedical Sub-center has engaged with 68 universities and selected 1,123 pharmaceutical achievements, leading to the establishment of 31 projects [1] - The sub-center provides significant support to startups, including access to expensive laboratory equipment, which alleviates financial burdens for new companies [1] - The rapid establishment of companies, such as Innos (Nanjing) Biotechnology Co., demonstrates the effectiveness of the sub-center in facilitating research commercialization [1] Group 2 - A comprehensive financial support system of 8.4 billion yuan has been established, encompassing government funding, angel funds, and bank loans [2] - The sub-center has developed a team of over 140 technical managers to provide one-stop support for university teams, aiding in the swift establishment and growth of projects [2] - Future plans for the sub-center include enhancing collaboration with universities and enterprises to promote high-quality development in the biomedical industry [2]

Group 1 - The event focused on enhancing the biopharmaceutical industry in Jiande, aiming for regional collaboration and innovative integration [1] - The Jiande Liaison Group of the Municipal Political Consultative Conference has been actively exploring innovative approaches to support local economic development [1] - The inspection team visited several companies and development projects to assess progress and future plans in the biopharmaceutical sector [1] Group 2 - The meeting emphasized the importance of aligning with national and local policies to strengthen the biopharmaceutical industry and improve economic stability [2] - Suggestions were made regarding innovation in development models, precise investment attraction, and policy support to enhance industrial clustering [1][2] - An intention to cooperate was established between Jiande Economic Development Zone and Puhua Capital, indicating potential investment opportunities [1]

Group 1 - In the first quarter, the total import and export value of medical device products in the Pudong Airport Comprehensive Bonded Zone reached 1.129 billion yuan, a year-on-year increase of 397.36% [1][2] - The opening of the BD Medical Pudong Airport Bonded Zone Distribution Center and the BD Medical Greater China R&D Center in Shanghai marks the first project in the Shanghai Free Trade Zone that integrates self-operated medical device international distribution and R&D functions, with an expected annual import and export total of 2 billion yuan after operation [1] - The BD Medical Greater China R&D Center in Shanghai has established three world-class laboratories covering mechanical, electronic, and chemical research fields, and is currently working on multiple product projects in the interventional and medical sectors [1] Group 2 - The management bureau of the bonded zone has implemented a three-in-one service mechanism to ensure the rapid implementation of projects, providing customized service plans and a green channel for approvals [2] - With the support of industry authorities, the company obtained the necessary medical device licenses in about a week, achieving a breakthrough in approval service efficiency [2] - The Pudong Airport Comprehensive Bonded Zone is becoming a hub for the biomedical industry, with various distribution centers for companies like Dongsong Medical, Contis, and Siemens Diagnostics being established [2] Group 3 - In the future, the Pudong Airport Comprehensive Bonded Zone will leverage the advantages of the Free Trade Zone and the International Business Cooperation Zone to optimize the business environment and accelerate the gathering and rapid development of the biomedical industry [3] - The goal is for the bonded area to become a target market for medical device consumption, a source of innovation and R&D, and a manufacturing output location [3]

主办单位：中关村独角兽企业发展联盟、中关村联新生物医药产业联盟 媒体支持：思宇MedTech | 骨未来 | 眼未来 | 心未来 | MedRobot 承办单位： 北京集智未来人工智能产业创新基地有限公司 北京中关村科学城创新发展有限公司 路演时间： 2025年3月31日星期一上午 路演形式：现场路演 地点：量子银座（北京市.近知春路地铁站） 已邀请投资机构： （所有北京市国管、北京市区两级相关基金） 京国瑞基金管理公司、顺禧基金管理公司、北京高精尖基金、北京科创基金、中关村 资本、中关村科学城基金、星元资本、康桥资本、荷塘创投、首发展创投、启迪创投、中关村启航基金，等等。其他投资人也可以报名，请等待新通 知。 注：本期路演为 中关村论坛平行论坛"全球独角兽企业大会"的分论坛， 因此，对路演项目的阶段有所要求，请在提交报名后，等待我们联系。如果不 能参加本场，我们会安排到4月24日星期四。 联盟 面向 全国招 募 生物医药领域企业、研究机构 会员。 希望参加路演的企业报名方式 点击文末 "阅读原文 "填写报名表，或者复制链接到浏览器中填写。 https://docs.qq.com/form/page/DUFB ...